Edesa Biotech, Inc. (EDSA)
4.76
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 18:24
Edesa Biotech Total Liabilities (Quarterly) : 3.91M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.91M |
| March 31, 2026 | 2.188M |
| December 31, 2025 | 0.7562M |
| September 30, 2025 | 1.210M |
| June 30, 2025 | 0.6727M |
| March 31, 2025 | 0.9147M |
| December 31, 2024 | 1.900M |
| September 30, 2024 | 1.959M |
| June 30, 2024 | 2.361M |
| March 31, 2024 | 2.151M |
| December 31, 2023 | 1.987M |
| September 30, 2023 | 2.075M |
| June 30, 2023 | 1.569M |
| March 31, 2023 | 1.674M |
| December 31, 2022 | 1.401M |
| September 30, 2022 | 2.184M |
| June 30, 2022 | 5.704M |
| March 31, 2022 | 3.383M |
| December 31, 2021 | 1.794M |
| September 30, 2021 | 1.526M |
| June 30, 2021 | 1.074M |
| March 31, 2021 | 4.729M |
| December 31, 2020 | 1.033M |
| September 30, 2020 | 1.654M |
| June 30, 2020 | 1.123M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7017M |
| December 31, 2019 | 0.8557M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 0.8814M |
| December 31, 2018 | 0.592M |
| September 30, 2018 | 0.4934M |
| June 30, 2018 | 0.4146M |
| March 31, 2018 | 0.5898M |
| December 31, 2017 | 0.5744M |
| September 30, 2017 | 0.3209M |
| June 30, 2017 | 0.4253M |
| March 31, 2017 | 0.4334M |
| December 31, 2016 | 0.6021M |
| September 30, 2016 | 0.6236M |
| June 30, 2016 | 0.839M |
| March 31, 2016 | 0.6161M |
| December 31, 2015 | 0.7237M |
| September 30, 2015 | 2.381M |
| June 30, 2015 | 1.780M |
| March 31, 2015 | 2.904M |
| December 31, 2014 | 4.189M |
| August 31, 2014 | 6.773M |
| May 31, 2014 | 4.352M |
| February 28, 2014 | 7.404M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ProMIS Neurosciences, Inc. | 7.295M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.72M |
| Shareholders Equity (Quarterly) | 8.811M |
| Current Ratio | 2.757 |